Cite
APA Citation
Behrens, F., Koehm, M., Schwaneck, E. C., Schmalzing, M., Gnann, H., Greger, G., Tony, H., & Burkhardt, H. (2018). minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab. Rheumatology, 57, 1938–1946. http://access.bl.uk/ark:/81055/vdc_100095322448.0x00001e